A major scientific breakthrough has identified the Epstein-Barr virus (EBV) as the leading cause of multiple sclerosis (MS), ...

Researchers are launching a groundbreaking study to investigate how genetics and the Epstein-Barr virus may work together to ...

The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD).

FDA prioritizes review of tabelecleucel, a promising therapy for relapsed EBV+ PTLD, offering hope to patients with limited ...

In a major step towards early detection, University of South Australia researchers are investigating the biology behind multiple sclerosis (MS) to ...